Landscapes / Companies

Advenchen Laboratories, LLC not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved in China
Next date
AL3818, Phase 3 trial completes
Drugs
2
in active trials · 3 in all
Trials
3 active
4 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
—
Approved in China Dec 2027Phase 3 trial completes
—
Advenchen Laboratories Nanjing
Phase 1/2 7 Nov 2029Phase 1/2 trial completes

About

No active trial
Pegylated Liposomal Doxorubicin
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Advenchen Laboratories, LLC

Following is part of Solo: you see every change to Advenchen Laboratories, LLC the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in